Infectious Disease and Microbiology – Colorado Tick Fever Virus

Overview

Colorado tick fever (CTF) is an acute tick-borne viral infection caused by Colorado tick fever virus, a member of the genus Coltivirus. The illness is typically characterized by an acute febrile syndrome following exposure to infected ticks in endemic mountainous regions. Most infections are self-limited, although neurologic complications such as meningitis and encephalitis can occur, particularly in children.

Microbiology

Colorado tick fever virus is a nonenveloped, double-stranded RNA virus belonging to the coltivirus group. Unlike many other medically important arboviruses, which contain single-stranded RNA, coltiviruses possess a segmented double-stranded RNA genome.

Other tick-associated arboviral illnesses have historically been associated with viruses such as Kemerovo, Nairobi sheep disease/Ganjam, Lipovnik, Quaranfil, Bhanja, Thogoto, and Dugbe viruses, although these represent distinct viral groups and epidemiologic settings.

Incubation Period

Symptoms of Colorado tick fever usually develop approximately 5 days after the bite of an infected tick.

Epidemiology and Transmission

Colorado tick fever occurs primarily in the mountainous regions of the western United States and western Canada, particularly at elevations above approximately 5,000 feet (1,500 meters).

Humans acquire infection through the bite of an infected tick. Consequently, people who spend substantial time outdoors in endemic mountainous areas are at greatest risk. This includes hikers, campers, hunters, forestry workers, and people involved in other recreational or occupational activities that increase exposure to ticks.

Clinical Manifestations

Colorado tick fever usually presents as an acute febrile illness. Patients may develop fever and constitutional symptoms following the incubation period.

A characteristic feature described with this infection is a biphasic (“saddleback”) fever, in which the initial fever improves and then returns after a short afebrile interval.

Although most cases remain uncomplicated, infection can occasionally involve the central nervous system. Meningitis and encephalitis are important complications and occur disproportionately in children.

Diagnosis

Diagnosis can be established using serologic testing to demonstrate an immune response to Colorado tick fever virus.

The virus can also be identified by specialized laboratory techniques, including viral culture, although culture is not routinely required in typical clinical practice. Molecular assays may also be available through specialized or public-health laboratories.

Treatment

There is no specific antiviral therapy for Colorado tick fever.

Management is therefore supportive and symptomatic, with measures such as adequate hydration, rest, treatment of fever and pain, and monitoring for neurologic or other complications. Patients with significant CNS involvement may require hospitalization and more intensive supportive management.

Prevention

Prevention centers on avoiding tick bites, especially when visiting endemic mountainous regions. Protective measures include wearing clothing that reduces exposed skin, using appropriate tick repellents, avoiding heavily tick-infested vegetation when possible, and performing careful tick checks after outdoor activities.

Prompt removal of attached ticks is an important general tick-bite prevention measure.

High-Yield Clinical Pearls

Vector: Tick

Geography: Mountainous western United States and Canada, particularly >5,000 ft

Virus: Coltivirus

Genome: Double-stranded RNA

Envelope: Nonenveloped

Incubation: Approximately 5 days

Typical disease: Acute febrile illness, classically with biphasic fever

Important complication: Meningitis or encephalitis, especially in children

Diagnosis: Primarily serologic/molecular testing

Treatment: Supportive; no specific antiviral therapy

Prevention: Tick-bite avoidance